UTAH MED PRODS INC shareholders Q3 2023

UTAH MED PRODS INC's ticker is UTMD and the CUSIP is 917488108. A total of 92 filers reported holding UTAH MED PRODS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

UTAH MED PRODS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Penn Mutual Asset Management, LLC 36,283$3,120,3382.93%
Clean Yield Group 31,263$2,684,5541.19%
BARD ASSOCIATES INC 18,181$1,563,5660.65%
RICE HALL JAMES & ASSOCIATES, LLC 111,634$9,600,5240.61%
Ranger Investment Management 74,411$6,399,3460.42%
ISTHMUS PARTNERS, LLC 21,307$1,832,4020.26%
Cardinal Capital Management 11,581$999,3440.20%
Riverwater Partners LLC 2,354$202,4440.18%
GLOBEFLEX CAPITAL L P 9,338$803,0680.09%
JAMES INVESTMENT RESEARCH INC 4,292$369,1120.05%
Penobscot Investment Management Company, Inc. 4,000$344,0000.05%
BRANDES INVESTMENT PARTNERS, LP 27,079$2,328,7940.04%
Ancora Advisors LLC 16,657$1,432,5020.04%
Renaissance Technologies 205,514$17,6740.03%
ROYCE & ASSOCIATES LP 32,716$2,813,5760.03%
WINTON GROUP Ltd 3,713$319,3180.03%
MORGAN DEMPSEY CAPITAL MANAGEMENT LLC 896$77,0560.02%
Quadrature Capital Ltd 13,363$1,156,0330.02%
SEIZERT CAPITAL PARTNERS, LLC 5,260$452,3600.02%
T. Rowe Price Investment Management, Inc. 329,312$28,3210.02%
External links

This page lists UTAH MED PRODS INC's shareholders in Q3 2023. To view UTAH MED PRODS INC's shareholder history, click here.